Sarepta Therapeutics (SRPT) Change in Acquisitions & Divestments (2014 - 2026)

Sarepta Therapeutics has reported Change in Acquisitions & Divestments for 13 years, with the latest figure at $38.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 4.59% year-over-year to $38.9 million; the trailing twelve-month figure through Mar 2026 stood at $294.0 million (down 81.22% YoY), and the FY2025 full-year result was $295.9 million, down 85.22% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $38.9 million, down from $99.9 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $965.1 million in Q4 2024, with the low at $38.9 million in Q1 2026.
• Average Change in Acquisitions & Divestments over 5 years is $320.5 million, with a median of $348.7 million recorded in 2022.
• Year-over-year, Change in Acquisitions & Divestments jumped 1231.9% in 2022 and sank 91.47% in 2025.
• Tracing SRPT's Change in Acquisitions & Divestments over 5 years: stood at $446.5 million in 2022, then rose by 18.3% to $528.2 million in 2023, then soared by 82.71% to $965.1 million in 2024, then tumbled by 89.65% to $99.9 million in 2025, then sank by 61.09% to $38.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $38.9 million (Q1 2026), $99.9 million (Q4 2025), and $86.6 million (Q3 2025), per Business Quant data.

Peer Comparison